{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:05:01Z","timestamp":1781327101875,"version":"3.54.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/ckj\/sfw152","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T07:59:09Z","timestamp":1490342349000},"page":"450-454","source":"Crossref","is-referenced-by-count":25,"title":["Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy"],"prefix":"10.1093","volume":"10","author":[{"given":"Vinod","family":"Mathrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulfattah","family":"Alejmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u00e2n","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"key\n\t\t\t\t20171012131346_sfw152-B1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0272-6386(00)70258-7","article-title":"Changing incidence of glomerular diseases in adults","volume":"35","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.04321007","article-title":"Idiopathic membranous nephropathy: diagnosis and treatment","volume":"3","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B4","first-page":"8803","article-title":"Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis","volume-title":"Sci Rep","year":"2015"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1681\/ASN.2013121315","article-title":"Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy","volume":"26","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","year":"1995","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","article-title":"Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial","volume":"381","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/91.5.359","article-title":"Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency","volume":"91","year":"1998","journal-title":"QJM"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B11","first-page":"1","article-title":"Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group","volume":"56","year":"2001","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B12","doi-asserted-by":"crossref","first-page":"c154","DOI":"10.1159\/000079175","article-title":"Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis","volume":"97","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00108-010-2772-5","article-title":"[Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)]","volume":"52","year":"2011","journal-title":"Internist (Berl)"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.27371","article-title":"High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial","volume":"62","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2002.003574","article-title":"EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis","volume":"63","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-121-5-199409010-00003","article-title":"Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide","volume":"121","year":"1994","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1440-1797.2010.01427.x","article-title":"Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study","volume":"16","year":"2011","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171012131346_sfw152-B19","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.2007020166","article-title":"A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy","volume":"18","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/10\/4\/450\/19377049\/sfw152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T21:13:29Z","timestamp":1658870009000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ckj\/article\/10\/4\/450\/3077305\/Intravenous-cyclophosphamide-and-oral-prednisolone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,3,22]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfw152","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,3,22]]}}}